Articles for Pfizer (NYSE: PFE)

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.

Pfizer Inc & Allergan Inc Have Fallen Out Of Love, But What Does This Mean For Astrazeneca Plc & Shire Plc?

Could the split between Pfizer Inc (NYSE: PFI) and Allergan Inc (NYSE: AGN), mean that Astrazeneca Plc (LON: AZN) is back in play, or... More »

Is It Game Over For AstraZeneca plc Shareholders?

Pfizer Inc. (NYSE:PFE) is not going to make a comeback for AstraZeneca plc (LON:AZN), whose shareholders are in trouble now, argues Alessandro Pasetti. More »

How Pfizer Inc. Could Push AstraZeneca plc Down To 3,100p

AstraZeneca plc (LON:AZN) is a volatile business that will disappoint shareholders if Pfizer Inc. (NYSE:PFE) doesn't make a comeback, argues Alessandro Pasetti. More »

Will Pfizer Inc. Make A Bid For GlaxoSmithKline plc?

Will Pfizer Inc. (NYSE:PFE) bid for GlaxoSmithKline plc (LON: GSK) or AstraZeneca plc (LON: AZN)? More »

One Reason Why AstraZeneca plc Is A Risky Bet

It's tough for AstraZeneca plc (LON:AZN) shareholders, argues Alessandro Pasetti. More »

Who Can Pfizer Inc. Afford?

Are Bristol-Myers Squibb Co (NYSE: BMY) or Shire PLC (LON:SHP) on Pfizer Inc. (NYSE:PFE)'s shopping list? More »

AstraZeneca plc: Time To Cash In?

There are several reasons why Astra (LON:AZN) investors may want to cash in now, argues Alessandro Pasetti More »

Lessons From The Great Investors… On Coca-Cola And AstraZeneca plc

AstraZeneca plc (LON: AZN) and Coca-Cola are the quintessential investments of two of the all-time greats. More »

What You Need To Know About AstraZeneca plc Rejecting Pfizer’s Final Offer

AstraZeneca plc (LON: AZN) will live on as a standalone entity with ambitious revenue targets and a buzzing drugs pipeline. More »

What Could Pfizer-AstraZeneca Be Like?

What might be the positives from this potential takeover? More »

Would A Combined AstraZeneca plc/Pfizer Inc. Be Worth Owning?

AstraZeneca plc's (LON: AZN) strengths as a separate entity won't be best harnessed by Pfizer Inc. (NYSE:PFE) More »

Is The Pfizer Takeover Offer for AstraZeneca plc ‘Un-American’?

Pfizer Inc. (NYSE:PFE) has AstraZeneca plc (LON:AZN) firmly in its sights as a home for the $69bn of earnings it has stashed in offshore... More »

Your browser (Internet Explorer 8 or older) is out of date. It has known security flaws and may not display all features of this and other websites. We recommend updating to Google Chrome.